Vancouver’s LightIntegra Technology has raised a $6.9 million Series A round led by Genome BC and Boardwalk Ventures and including Tower Beach Capital, Coleco Investments, and Quimby Investments. The company intends to use funding to bring its test to the US market. LightIntegra has advanced ThromboLUX, a non-invasive, five-minute, easy-to-use optical test that assesses platelet […]